SCHEMBL5634824

SCHEMBL5634824

CN1C2CCC1CC(Sc1c(Cl)cc(N)cc1Cl)C2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 3/20 0.38
CHRM1 P11229 2/20 0.38
SLC6A4 P31645 2/20 0.38
HTR4 Q13639 1/20 0.36
HTR3E A5X5Y0 1/20 0.35
GMNN O75496 1/20 0.35
HTR3B O95264 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35
MTOR P42345 1/20 0.35
HTR3A P46098 1/20 0.35
PMP22 Q01453 1/20 0.35
HTR3D Q70Z44 1/20 0.35
HTR3C Q8WXA8 1/20 0.35
HSD17B10 Q99714 1/20 0.35
SLC6A3 Q01959 2/20 0.34
DRD3 P35462 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5636332 0.84 CHRM1 (0.38) SLC6A2CHRM1SLC6A4HTR4HTR3E
SCHEMBL5664764 0.81 PDE7A (0.41) SLC6A2CHRM1SLC6A4TSHRSLC6A3
SCHEMBL14573390 0.81 PDE7A (0.41) SLC6A2CHRM1SLC6A4TSHRSLC6A3
SCHEMBL5635931 0.80 ALDH1A1 (0.41) SLC6A2CHRM1SLC6A4HTR3EGMNN
SCHEMBL5635927 0.80 ALDH1A1 (0.41) SLC6A2CHRM1SLC6A4HTR3EGMNN
SCHEMBL4873667 0.78 KDM4E (0.41) HTR4ALOX15GAA
SCHEMBL5636307 0.72 SLC6A2 (0.40) SLC6A2SLC6A4SLC6A3
SCHEMBL5636304 0.72 SLC6A2 (0.40) SLC6A2SLC6A4SLC6A3
SCHEMBL1177474 0.72 SLC6A4 (0.50) SLC6A2CHRM1SLC6A4SLC6A3DRD3
SCHEMBL1177473 0.72 SLC6A4 (0.50) SLC6A2CHRM1SLC6A4SLC6A3DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070054912-A1 Modulators of acetylcholine receptors ASTLES PETER C 2007-03-08 US disclosed
US-7148236-B2 Modulators of acetylcholine receptors MERCK & CO., INC. (US) 2006-12-12 US disclosed
US-20050182088-A1 Modulators of acetylcholine receptors MERCK SHARP & DOHME CORP. 2005-08-18 US disclosed
EP-1472248-A1 MODULATORS OF ACETYLCHOLINE RECEPTORS ELI LILLY AND COMPANY (US) 2004-11-03 EP disclosed
WO-2003062235-A1 MODULATORS OF ACETYLCHOLINE RECEPTORS ELI LILLY AND COMPANY (US) 2003-07-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050182088-A1 Modulators of acetylcholine receptors CHRM3, CHRNG, CHRM5 SLC6A2 46/4885CHRM1 22/4885SLC6A4 153/4885
US-20070054912-A1 Modulators of acetylcholine receptors CHRM3, CHRNG, CHRM5 SLC6A2 232/4885CHRM1 17/4885SLC6A4 372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.